Combined drug therapy of hemorrhoidal bleeding
https://doi.org/10.21518/akh2025-017
Abstract
Hemorrhoidal disease is one of the most common proctological pathologies. The main risk factors are physical inactivity, obesity, pregnancy, and chronic constipation, including dysynergic bowel movements. Systemic bioflavonoids (diosmin and hesperidin) demonstrate high efficacy, especially in the early stages of the disease. These substances strengthen blood vessels, reduce inflammation and improve microcirculation. Studies confirm that the combination of systemic flavonoids with topical agents such as sodium alginate accelerates the regression of symptoms. Sodium alginate in the form of candles has hemostatic, wound-healing and anti-inflammatory effects. When comparing the isolated use of bioflavonoids (Venarus® ) and combination therapy (Venarus® and Venaproct Alium), it was demonstrated that the combination of drugs is more effective in reducing the frequency of bleeding, reducing the size of hemorrhoids and reducing the frequency of relapses. The presented authors’ own experience demonstrates that the use of Venarus® and Venaproсt Allium drugs is effective in bleeding hemorrhoids. The results of treatment of 23 patients (11 men/12 women), aged 43 ± 5 years, who came for an initial consultation with complaints of blood discharge from the anus during defecation and who had not previously undergone colon examination, were analyzed. The use of a combination of Venarus® and Venaproct Alium, taking into account the therapeutic effects of each of the drugs, may be promising not only as an independent conservative therapy for hemorrhoids, but also at the stage of rehabilitation after surgical interventions, this requires further research.
About the Authors
M. V. Abritsova
Multidisciplinary Clinic Real Trans Hair
Russian Federation
Russian Federation
Maryana V. Abritsova, Cand. Sci. (Med.), Coloproctologist, Сhief of Coloproctology Department,
6, 3rd Roshinskay St., Moscow, 115191
N. R. Torchua
Multidisciplinary Clinic Real Trans Hair
Russian Federation
Russian Federation
Nina R. Torchua, Cand. Sci. (Med.), Coloproctologist,
6, 3rd Roshinskay St., Moscow, 115191
References
1. Шелыгин ЮА, Благодарный ЛА. Справочник колопроктолога.М.: ЛитТера; 2012. 596 с.
2. Veselov AV, Omelyanovskiy VV, Moskalev AI, Shkurko TV, Serbina AA, Kots NA et al. Medical care for hemorrhoids in the federal subjects of Russia in 2018. Koloproktologia. 2020;19(3):126–134. (In Russ.) https://doi.org/10.33878/2073-7556-2020-19-3-126-134.
3. Godeberge P, Sheikh P, Zagriadskiĭ E, Lohsiriwat V, Montaño AJ, Košorok P, De Schepper H. Hemorrhoidal disease and chronic venous insufficiency: Concomitance or coincidence; results of the CHORUS study (Chronic venous and HemORrhoidal diseases evalUation and Scientific research). J Gastroenterol Hepatol. 2020;35(4):577–585. https://doi.org/10.1111/jgh.14857.
4. Bogomazov AM, Golovko EB, Zgryadsky EA. Incidence of hemorrhoid occurrence risk factors and definition of the relationship between hemorrhoids and chronic vein diseases. Results of the russian part of the international program CHORUS. Ambulatornaya Khirurgiya. 2017;(3-4):94–104. (In Russ.) Available at: https://www.a-surgeon.ru/jour/article/view/97.
5. Алиев ФШ, Ачкасов СИ, Башанкаев БН, Благодарный ЛА, Вышегородцев ДВ, Григорьев ЕГ и др. Геморрой: клинические рекомендации. М.; 2024. Режим доступа: Режим доступа: https://cr.minzdrav.gov.ru/view-cr/178_2.
6. Abritsova MV. The optimal choice of therapy for acute haemorrhoids. Ambulatornaya Khirurgiya. 2019;(1–2):118–123. (In Russ.) https://doi.org/10.21518/1995-1477-2019-1-2-118-123.
7. Rivadeneira DE, Steele SR, Ternent C, Chalasani S. Practice Parameters for the Management of Hemorrhoids (Revised 2010). The Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Dis Colon Rectum. 2011;54(9):1059–1064. Available at: https://pubmed.ncbi.nlm.nih.gov/8253007.
8. Ratto C. THD Doppler procedure for hemorrhoids: the surgical technique. Tech Coloproctol. 2014;18(3):291–298. https://doi.org/10.1007/s10151-013-1062-3.
9. Margetis N. Pathophysiology of internal hemorrhoids. Ann Gastroenterol. 2019;32(3):264–272. https://doi.org/10.20524/aog.2019.0355.
10. Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel Disorders. Gastroenterology. 2016;S0016-5085(16)00222-5. https://doi.org/10.1053/j.gastro.2016.02.031.
11. Van Meegdenburg MM, Trzpis M, Heineman E, Broens PM. Increased anal basal pressure in chronic anal fissures may be caused by overreaction of the anal-external sphincter continence reflex. Med Hypotheses. 2016;(94):25–29. https://doi.org/10.1016/j.mehy.2016.06.005.
12. Rao SS, Rattanakovit K, Patcharatrakul T. Diagnosis and management of chronic constipation in adults. Nat Rev Gastroenterol Hepatol. 2016;13(5):295–305. https://doi.org/10.1038/nrgastro.2016.53.
13. Schmulson MJ, Drossman DA. What is new in rome IV. J Neurogastroenterol Motil. 2017;23(2):151–163. https://doi.org/10.5056/jnm16214.
14. Rodin AV, Danilenkov NV, Agafonov OI, Privolnev VV. Conservative treatment for chronic hemorrhoids. Results of survey of Russian surgeons. Koloproktologia. 2019;18(2):69–74. (In Russ.) https://doi.org/10.33878/2073-7556-2019-18-2-69-74.
15. Lyseng-Williamson KA, Perry CM. Micronised Purified Flavonoid Fraction. Drugs. 2003;63(1):71–100. https://doi.org/10.2165/00003495-200363010-00005.
16. Karetová D, Suchopár J, Bultas J. Diosmin/hesperidin: a cooperating tandem, or is diosmin crucial and hesperidin an inactive ingredient only? Vnitr Lek. 2020;66(2):97–103. (In Czech.)
17. Zagryadskiy EA, Bogomazov AM, Golovko EB. Conservative treatment of hemorrhoids an alternative to surgical methods or components? CHORUS program results. Koloproktologia. 2018;(1):27–35. (In Russ.) https://doi.org/10.33878/2073-7556-2018-0-1-27-35.
18. Kostarev IV, Rodoman GV, Batishev AK, Bogormistrov IS, Tuktagulov NV. Systemic andlocal therapy of chronic hemorrhoids: Results of the prospective comparative study “VITA”. Ambulatornaya Khirurgiya. 2024;21(2):153–163. (In Russ.) https://doi.org/10.21518/akh2024-045.
19. Parhiz H, Roohbakhsh A, Soltani F, Rezaee R, Iranshahi M. Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models. Phytother Res. 2015;29(3):323–331. https://doi.org/10.1002/ptr.5256.
20. Shih EV, Hajtovich ED. Own clinical and pharmacological effects of hesperidin in the treatment of chronic venous diseases. Lechebnoe Delo. 2023;(4):17–31. (In Russ.) https://doi.org/10.24412/2071-5315-2023-13018.
21. Mustafa S, Akbar M, Khan MA, Sunita K, Parveen S, Pawar JS et al. Plant metabolite diosmin as the therapeutic agent in human diseases. Curr Res Pharmacol Drug Discov. 2022;3:100122. https://doi.org/10.1016/j.crphar.2022.100122.
22. Alonso-Coello P, Zhou Q, Martinez-Zapata MJ, Mills E, Heels-Ansdell D, Johanson JF, Guyatt G. Meta-analysis of flavonoids for the treatment of haemorrhoids. Br J Surg. 2006;93(8):909–920. https://doi.org/10.1002/bjs.5378.
23. Perera N, Liolitsa D, Iype S, Croxford A, Yassin M, Lang P et al. Phlebotonics for haemorrhoids. Cochrane Database Syst Rev. 2012;(8):CD004322. https://doi.org/10.1002/14651858.CD004322.pub3.
24. Mayet N, Choonara YE, Kumar P, Tomar LK, Tyagi C, Du Toit, Pillay LC. A comprehensive review of advanced biopolymeric wound healing systems. J Pharm Sci. 2014;103(8):2211–2230. https://doi.org/10.1002/jps.24068.
25. Shikh EV, Anikin GS, Fedorova TA. Clinical and pharmacological aspects of the use of alginates in the pharmacotherapy of chronic hemorrhoids. Lechebnoe Delo. 2024;(3):17–23. (In Russ.) https://doi.org/10.24412/2071-5315-2024-13168.
26. Summa M, Russo D, Penna I, Margaroli N, Bayer IS, Bandiera T et al. A biocompatible sodium alginate/povidone iodine film enhances wound healing. Eur J Pharm Biopharm. 2018;122:17–24. https://doi.org/10.1016/j.ejpb.2017.10.004.
27. Taskin AK, Yasar M, Ozaydin I, Kaya B, Bat O, Ankaral S et al. The hemostatic effect of calcium alginate in experimental splenic injury model. Ulus Travma Acil Cerrahi Derg. 2013;19(3):195–199. https://doi.org/10.5505/tjtes.2013.30676.
28. Lee WR, Park JH, Kim KH, Kim SJ, Park DH, Chae MH et al. The biological effects of topical alginate treatment in an animal model of skinwound healing. Wound Repair Regen. 2009;17(4):505–510. https://doi.org/10.1111/j.1524 475X.2009.00496.x.
Review
For citations:
Abritsova M.V., Torchua N.R. Combined drug therapy of hemorrhoidal bleeding. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2025;22(1):153-159. (In Russ.) https://doi.org/10.21518/akh2025-017
Views:
523
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International.
Email this article 